{
  "trial_id": "NCT02033889",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gender, Body Mass Index (BMI), Duration of Type 2 Diabetes Mellitus, Baseline Hemoglobin A1c (HbA1c), Baseline Fasting Plasma Glucose, Blood Pressure, Lipid Profile, Renal Function (e.g., eGFR), Concomitant Medications, Smoking Status, Ethnicity, Race, History of Cardiovascular Disease, Baseline Metformin Dose.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Gender"
        ],
        [
          "Baseline Hemoglobin A1C (A1C)",
          "Baseline Hemoglobin A1c (HbA1c)"
        ],
        [
          "Fasting Plasma Glucose (FPG)",
          "Baseline Fasting Plasma Glucose"
        ],
        [
          "Race (NIH/OMB)",
          "Race"
        ],
        [
          "Estimated Glomerular Filtration Rate (eGFR)",
          "Renal Function (e.g., eGFR)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Body Weight",
        "Sitting Systolic Blood Pressure (SBP)",
        "Diastolic Blood Pressure (DBP)",
        "Bone Mineral Density (BMD) as Measured by Dual Energy X-Ray Absorptiometry (DXA) of the Femoral Neck",
        "BMD as Measured by DXA of the Lumbar Spine (L1-L4)",
        "BMD as Measured by DXA of the Total hip",
        "BMD as Measured by DXA at the Distal Forearm",
        "Bone Biomarker Carboxy-Terminal Cross-Linking Telopeptides of Type I Collagen (CTX)",
        "Bone Biomarker Procollagen Type I N-terminal Propeptide (P1NP)",
        "Bone Biomarker Parathyroid Hormone (PTH)",
        "Menopausal Status"
      ],
      "remaining_candidate_features": [
        "Body Mass Index (BMI)",
        "Duration of Type 2 Diabetes Mellitus",
        "Blood Pressure",
        "Lipid Profile",
        "Concomitant Medications",
        "Smoking Status",
        "Ethnicity",
        "History of Cardiovascular Disease",
        "Baseline Metformin Dose"
      ]
    },
    "processed-gen-response": "Age, Gender, Body Mass Index (BMI), Duration of Type 2 Diabetes Mellitus, Baseline Hemoglobin A1c (HbA1c), Baseline Fasting Plasma Glucose, Blood Pressure, Lipid Profile, Renal Function (e.g., eGFR), Concomitant Medications, Smoking Status, Ethnicity, Race, History of Cardiovascular Disease, Baseline Metformin Dose."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline HbA1c, Duration of Diabetes, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Plasma Glucose, Use of Antihyperglycemic Agents,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Baseline Hemoglobin A1C (A1C)",
          "Baseline HbA1c"
        ],
        [
          "Fasting Plasma Glucose (FPG)",
          "Fasting Plasma Glucose"
        ],
        [
          "Sitting Systolic Blood Pressure (SBP)",
          "Systolic Blood Pressure"
        ],
        [
          "Diastolic Blood Pressure (DBP)",
          "Diastolic Blood Pressure"
        ]
      ],
      "remaining_reference_features": [
        "Body Weight",
        "Bone Mineral Density (BMD) as Measured by Dual Energy X-Ray Absorptiometry (DXA) of the Femoral Neck",
        "BMD as Measured by DXA of the Lumbar Spine (L1-L4)",
        "BMD as Measured by DXA of the Total hip",
        "BMD as Measured by DXA at the Distal Forearm",
        "Bone Biomarker Carboxy-Terminal Cross-Linking Telopeptides of Type I Collagen (CTX)",
        "Bone Biomarker Procollagen Type I N-terminal Propeptide (P1NP)",
        "Bone Biomarker Parathyroid Hormone (PTH)",
        "Menopausal Status",
        "Estimated Glomerular Filtration Rate (eGFR)"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Duration of Diabetes",
        "Body Mass Index",
        "Use of Antihyperglycemic Agents"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Baseline HbA1c, Duration of Diabetes, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Plasma Glucose, Use of Antihyperglycemic Agents"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Diagnosis Duration, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Hemoglobin A1c, Fasting Plasma Glucose, Metformin Dose, History of Cardiovascular Disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Baseline Hemoglobin A1C (A1C)",
          "Hemoglobin A1c"
        ],
        [
          "Fasting Plasma Glucose (FPG)",
          "Fasting Plasma Glucose"
        ],
        [
          "Sitting Systolic Blood Pressure (SBP)",
          "Systolic Blood Pressure"
        ],
        [
          "Diastolic Blood Pressure (DBP)",
          "Diastolic Blood Pressure"
        ]
      ],
      "remaining_reference_features": [
        "Body Weight",
        "Bone Mineral Density (BMD) as Measured by Dual Energy X-Ray Absorptiometry (DXA) of the Femoral Neck",
        "BMD as Measured by DXA of the Lumbar Spine (L1-L4)",
        "BMD as Measured by DXA of the Total hip",
        "BMD as Measured by DXA at the Distal Forearm",
        "Bone Biomarker Carboxy-Terminal Cross-Linking Telopeptides of Type I Collagen (CTX)",
        "Bone Biomarker Procollagen Type I N-terminal Propeptide (P1NP)",
        "Bone Biomarker Parathyroid Hormone (PTH)",
        "Menopausal Status",
        "Estimated Glomerular Filtration Rate (eGFR)"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Diabetes Diagnosis Duration",
        "Body Mass Index",
        "Metformin Dose",
        "History of Cardiovascular Disease."
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Diabetes Diagnosis Duration, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Hemoglobin A1c, Fasting Plasma Glucose, Metformin Dose, History of Cardiovascular Disease."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes mellitus, hemoglobin A1c (HbA1c) at baseline, fasting plasma glucose at baseline, systolic blood pressure at baseline, diastolic blood pressure at baseline, low-density lipoprotein (LDL) cholesterol at baseline, high-density lipoprotein (HDL) cholesterol at baseline, triglycerides at baseline, metformin dose at baseline, history of cardiovascular disease, history of hypertension, history of dyslipidemia.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Baseline Hemoglobin A1C (A1C)",
          "hemoglobin A1c (HbA1c) at baseline"
        ],
        [
          "Fasting Plasma Glucose (FPG)",
          "fasting plasma glucose at baseline"
        ],
        [
          "Body Weight",
          "body mass index (BMI)"
        ],
        [
          "Sitting Systolic Blood Pressure (SBP)",
          "systolic blood pressure at baseline"
        ],
        [
          "Diastolic Blood Pressure (DBP)",
          "diastolic blood pressure at baseline"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Bone Mineral Density (BMD) as Measured by Dual Energy X-Ray Absorptiometry (DXA) of the Femoral Neck",
        "BMD as Measured by DXA of the Lumbar Spine (L1-L4)",
        "BMD as Measured by DXA of the Total hip",
        "BMD as Measured by DXA at the Distal Forearm",
        "Bone Biomarker Carboxy-Terminal Cross-Linking Telopeptides of Type I Collagen (CTX)",
        "Bone Biomarker Procollagen Type I N-terminal Propeptide (P1NP)",
        "Bone Biomarker Parathyroid Hormone (PTH)",
        "Menopausal Status",
        "Estimated Glomerular Filtration Rate (eGFR)"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "duration of type 2 diabetes mellitus",
        "low-density lipoprotein (LDL) cholesterol at baseline",
        "high-density lipoprotein (HDL) cholesterol at baseline",
        "triglycerides at baseline",
        "metformin dose at baseline",
        "history of cardiovascular disease",
        "history of hypertension",
        "history of dyslipidemia"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes mellitus, hemoglobin A1c (HbA1c) at baseline, fasting plasma glucose at baseline, systolic blood pressure at baseline, diastolic blood pressure at baseline, low-density lipoprotein (LDL) cholesterol at baseline, high-density lipoprotein (HDL) cholesterol at baseline, triglycerides at baseline, metformin dose at baseline, history of cardiovascular disease, history of hypertension, history of dyslipidemia."
  }
}